According to its report, Dong-A Pharm's Korean market share in the field of prescription drugs, ranked 5th in 2004, has been rising very rapidly and showed the similar level of Hanmi Pharm (ranked 2th) in February 2009.
In the first quarter of this year, Dong-A's sales of prescription drugs hold 63 % of its total sales.
An researcher of WOORI Investment & Securities said, "This upward tendency of Dong-A Pharm will be continued, and Dong-A will be ranked first this year." <헬스코리아뉴스>
저작권자 © 헬스코리아뉴스 무단전재 및 재배포 금지